CASE DISCUSSION
Innovations in Cancer Therapy
Presented India by Dr. G. V. Nagarjuna ReddyViews
54,796
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Innovations in Cancer Therapy have revolutionized treatment by offering more precise, effective, and less invasive options. Immunotherapy, including checkpoint inhibitors and CAR-T cell therapy, enhances the body's natural defense against cancer. Targeted therapies focus on specific genetic...
Case Summary
- Cancer incidence is on the rise globally, especially in developing countries like India, necessitating increased awareness and advancements in treatment. The theme for World Cancer Day (2025-2027) is "United by Uni", emphasizing collaborative efforts in cancer care.
Speaker Profile
Dr. G. V. Nagarjuna Reddy
Head & Neck Oncosurgeon, MAA ENT Hospitals, Hyderabad.Dr. G V Nagarjuna Reddy, a distinguished Consultant Head and Neck Surgical Oncologist, completed his MBBS from KMC and M.S. ENT from PGIMER Chandigarh. With a wealth of experience and expertise, he has served as a Senior Resident at Tata Memorial Hospital Mumbai and pursued fellowships in Head and Neck Surgical Oncology with prestigious institutions such as IFHNOS (International Federation of Head and Neck Oncologic Societies), RCS (London), and HCG Hospital Bangalore. Dr. Reddy's specialization includes the diagnosis and treatment of various head and neck conditions, encompassing benign lesions like thyroglossal cysts, submandibular stones, and branchial cysts, as well as complex cases such as nerve sheath tumors, head and neck cancers, laryngectomy, voice prosthesis, thyroid swellings, parotid swellings and cancers, and nasal bleeding and cancers. His extensive training and dedication to advancing surgical oncology make him a valuable asset in the field of head and neck oncology.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.